Skip to content
2000
Volume 25, Issue 1
  • ISSN: 1871-5265
  • E-ISSN: 2212-3989

Abstract

Urinary Tract Infection (UTI) is a common bacterial infection that can affect various parts of the urinary system, with symptoms including frequent urination, painful urination, and lower back pain. UTIs are more common in women due to their shorter urethra, and they can lead to serious complications if left untreated. Vaginitis is an inflammation or infection of the vagina caused by factors like bacteria, fungi (Candida), or protozoa (Trichomonas). Symptoms include vaginal itching, abnormal discharge, and discomfort during urination or sexual activity. Treatment depends on the underlying cause and may involve antifungal or antimicrobial medications. Vaginal infections, such as bacterial vaginosis, yeast infections, trichomoniasis, cervicitis, and atrophic vaginitis, can have various physical, emotional, sexual, and social impacts on the lives of women. These impacts may include discomfort, embarrassment, reduced sexual satisfaction, social isolation, and emotional distress. Support and resources for managing these infections include healthcare providers who can diagnose and prescribe treatment, pharmacies that provide medications and guidance, telemedicine for remote consultations and prescriptions, support groups for emotional and informational support, and online resources for reliable information. They offer a sense of community, information sharing, and emotional support, making it easier for individuals to manage their vaginitis and related concerns. Utilizing these resources can contribute to a more informed and empowered approach to vaginal infection prevention and treatment.

Loading

Article metrics loading...

/content/journals/iddt/10.2174/0118715265286164240508064714
2024-05-31
2025-01-11
Loading full text...

Full text loading...

References

  1. BecerraA.M. ParraD. TrujilloC.G. Uncomplicated urinary tract infections in women.Urol Colomb20213012313410.1055/s‑0040‑1721323
    [Google Scholar]
  2. EjrnæsK. Bacterial characteristics of importance for recurrent urinary tract infections caused by Escherichia coli.Dan. Med. Bull.2011584B4187 21466767
    [Google Scholar]
  3. LinW.H. KaoC.Y. YangD.C. Clinical and microbiological characteristics of Klebsiella pneumoniae from community-acquired recurrent urinary tract infections.Eur. J. Clin. Microbiol. Infect. Dis.20143391533153910.1007/s10096‑014‑2100‑4 24756209
    [Google Scholar]
  4. SchneiderP.F. RileyT.V. Staphylococcus saprophyticus urinary tract infections: epidemiological data from Western Australia.Eur. J. Epidemiol.1996121515410.1007/BF00144428 8817178
    [Google Scholar]
  5. SK Al-Khafaji N, T Al-Alaq F Virulence and Antibiotic Resistance of Acinetobacter baumannii among Urinary Tract Infections.Urin. Tract Infect. Nephrop. - Insights into Potential Relatsh202210.5772/intechopen.94508
    [Google Scholar]
  6. FelminghamD. WilsonA.P.R. QuintanaA.I. GrünebergR.N. Enterococcus species in urinary tract infection.Clin. Infect. Dis.199215229530110.1093/clinids/15.2.295 1387807
    [Google Scholar]
  7. KhawaldehA. MoralesS. DillonB. Bacteriophage therapy for refractory Pseudomonas aeruginosa urinary tract infection.J. Med. Microbiol.201160111697170010.1099/jmm.0.029744‑0 21737541
    [Google Scholar]
  8. StormeO. Tirán SaucedoJ. Garcia-MoraA. Dehesa-DávilaM. NaberK.G. Risk factors and predisposing conditions for urinary tract infection.Ther. Adv. Urol.20191110.1177/1756287218814382 31105772
    [Google Scholar]
  9. CzajkowskiK. Broś-KonopielkoM. Teliga-CzajkowskaJ. Urinary tract infection in women.Przegl. Menopauz.2021201404710.5114/pm.2021.105382 33935619
    [Google Scholar]
  10. Clinical guideline for the diagnosis and treatment of urinary tract infections: Asymptomatic bacteriuria, uncomplicated & complicated urinary tract infections, bacterial prostatitis.Infect. Chemother.201143112510.3947/ic.2011.43.1.1
    [Google Scholar]
  11. PreheimL.C. Complicated urinary tract infections.Am. J. Med.1985792626610.1016/0002‑9343(85)90263‑3 3895920
    [Google Scholar]
  12. MarnachM.L. WygantJ.N. CaseyP.M. Evaluation and Management of Vaginitis.Mayo Clin. Proc.202297234735810.1016/j.mayocp.2021.09.022 35120697
    [Google Scholar]
  13. Al-BadrA. Al-ShaikhG. Recurrent Urinary Tract Infections Management in Women: A Review.Sultan Qaboos Univ. Med. J.201313335936710.12816/0003256 23984019
    [Google Scholar]
  14. MenardJ.P. Antibacterial treatment of bacterial vaginosis: current and emerging therapies.Int. J. Womens Health2011329530510.2147/IJWH.S23814 21976983
    [Google Scholar]
  15. DuttaC. PashaK. PaulS. Urinary tract infection induced delirium in elderly patients: A systematic review.Cureus20221412e3232110.7759/cureus.32321 36632270
    [Google Scholar]
  16. ChenY. BruningE. RubinoJ. EderS.E. Role of female intimate hygiene in vulvovaginal health: Global hygiene practices and product usage.Womens Health (Lond. Engl.)2017133586710.1177/1745505717731011 28934912
    [Google Scholar]
  17. KranzJ. WagenlehnerF.M.E. SchneidewindL. Complicated urinary tract infections.Urologe A202059121480148510.1007/s00120‑020‑01343‑1 33025113
    [Google Scholar]
  18. Flores-MirelesA.L. WalkerJ.N. CaparonM. HultgrenS.J. Urinary tract infections: epidemiology, mechanisms of infection and treatment options.Nat. Rev. Microbiol.201513526928410.1038/nrmicro3432 25853778
    [Google Scholar]
  19. SihraN. MaldeS. GreenwellT. PakzadM. KujawaM. SinclairA. Management of recurrent urinary tract infections in women.J. Clin. Urol.202215215216410.1177/2051415820939456
    [Google Scholar]
  20. TchopbaC.N. KatawaG. PadaroE. Systemic t cell subsets and cytokines in patients with homozygous sickle cell disease and asymptomatic urinary tract infections in Togo.Ochsner J.202121216317210.31486/toj.20.0061 34239376
    [Google Scholar]
  21. MoriyaK. NakamuraM. NishimuraY. Prevalence of and risk factors for symptomatic urinary tract infection after endoscopic incision for the treatment of ureterocele in children.BJU Int.2017120340941510.1111/bju.13884 28432830
    [Google Scholar]
  22. DemeC. EdaoB. JayaG. Prevalence of hypertension, anemia, asymptomatic urinary tract infection, syphilis, hiv and hepatitis b virus infection among pregnant women attending an antenatal clinic at a rural hospital in southern ethiopia.Southeast Asian J. Trop. Med. Public Health201647510321039 29620811
    [Google Scholar]
  23. Hernández-HernándezD. Padilla-FernándezB. Ortega-GonzálezM.Y. Castro-DíazD.M. Recurrent urinary tract infections and asymptomatic bacteriuria in adults.Curr. Bladder Dysfunct. Rep.202217111210.1007/s11884‑021‑00638‑z 34868442
    [Google Scholar]
  24. ChuangL. TambyahP.A. Catheter-associated urinary tract infection.J. Infect. Chemother.202127101400140610.1016/j.jiac.2021.07.022 34362659
    [Google Scholar]
  25. AddisT. MekonnenY. AyenewZ. FentawS. BiazinH. Bacterial uropathogens and burden of antimicrobial resistance pattern in urine specimens referred to Ethiopian Public Health Institute.PLoS One20211611e025960210.1371/journal.pone.0259602 34767605
    [Google Scholar]
  26. FarfordB. Management and prevention of recurrent urinary tract infections in women.Consultant20185899103
    [Google Scholar]
  27. MedinaM. Castillo-PinoE. An introduction to the epidemiology and burden of urinary tract infections.Ther. Adv. Urol.20191110.1177/1756287219832172 31105774
    [Google Scholar]
  28. AydinA. AhmedK. ZamanI. KhanM.S. DasguptaP. Recurrent urinary tract infections in women.Int. Urogynecol. J. Pelvic Floor Dysfunct.201526679580410.1007/s00192‑014‑2569‑5 25410372
    [Google Scholar]
  29. CoudrayM.S. MadhivananP. Bacterial vaginosis—A brief synopsis of the literature.Eur. J. Obstet. Gynecol. Reprod. Biol.202024514314810.1016/j.ejogrb.2019.12.035 31901667
    [Google Scholar]
  30. WillemsH.M.E. AhmedS.S. LiuJ. XuZ. PetersB.M. Vulvovaginal candidiasis: A current understanding and burning questions.J. Fungi (Basel)2020612710.3390/jof6010027 32106438
    [Google Scholar]
  31. MeitesE GaydosCA HobbsMM A review of evidence-based care of symptomatic trichomoniasis and asymptomatic Trichomonas vaginalis Infections.Clin Infect Dis201561Suppl 8)(Suppl. 8S8374810.1093/cid/civ738 26602621
    [Google Scholar]
  32. VasudevanR. Urinary tract infection: An overview of the infection and the associated risk factors.J. Microbiol. Exp.20141210.15406/jmen.2014.01.00008
    [Google Scholar]
  33. KimB. KimJ.H. LeeY. Virulence factors associated with Escherichia coli bacteremia and urinary tract infection.Ann. Lab. Med.202242220321210.3343/alm.2022.42.2.203 34635614
    [Google Scholar]
  34. KomalaM. BhowmikD. Sampath KumarK.P. Urinary tract infection: Causes, symptoms, diagnosis and it’s management.J Chem Pharm Sci20136
    [Google Scholar]
  35. GamitS.C. SingelH.V. JadejaM.I. Bacteriological profile and antibiotics sensitivity pattern of patients with urinary tract infection in tertiary care center, Pipariya, Vadodara, Gujarat.J. Pure Appl. Microbiol.20221642576257910.22207/JPAM.16.4.24
    [Google Scholar]
  36. AbrahamianF.M. KrishnadasanA. MowerW.R. MoranG.J. TalanD.A. Association of pyuria and clinical characteristics with the presence of urinary tract infection among patients with acute nephrolithiasis.Ann. Emerg. Med.201362552653310.1016/j.annemergmed.2013.06.006 23850311
    [Google Scholar]
  37. BehzadiP. BehzadiE. RanjbarR. Urinary tract infections and Candida albicans.Cent. European J. Urol.20156819610110.5173/ceju.2015.01.474 25914847
    [Google Scholar]
  38. KhalidF. BushraR. GhayasS. MushtaqueM. Case report: Urinary tract infection in a diabetic postmenopausal woman with multiple episodes of recurrence: An antimicrobial susceptibility dispute.Clin. Med. Insights Case Rep.20221510.1177/11795476221112819 35898804
    [Google Scholar]
  39. ElmhishiO. BaradhiK. HYDRONEPHROSIS FROM COAPTITE CRYSTALS IN A PATIENT WITH URINARY INCONTINENCE.Am. J. Kidney Dis.2015654A3310.1053/j.ajkd.2015.02.077
    [Google Scholar]
  40. LinY.P. ChenW.C. ChengC.M. ShenC.J. Vaginal ph value for clinical diagnosis and treatment of common vaginitis.Diagnostics (Basel)20211111199610.3390/diagnostics11111996 34829343
    [Google Scholar]
  41. SegalS. HarvieH.S. SiegelmanE. AryaL.A. Severe atrophic vaginitis causing vaginal synechiae and hematocolpos at menopause.Menopause201118333333510.1097/gme.0b013e3181f3285a 21301374
    [Google Scholar]
  42. FaubionS.S. SoodR. KapoorE. Genitourinary Syndrome of Menopause: Management Strategies for the Clinician.Mayo Clin. Proc.201792121842184910.1016/j.mayocp.2017.08.019 29202940
    [Google Scholar]
  43. RosenfeldJ.A. Vaginitis.In: Handbook of Women’s Health.2nd edStatPearls Publishing200916116610.1017/CBO9780511642111.013
    [Google Scholar]
  44. Abou ChacraL. FenollarF. DiopK. Bacterial vaginosis: What do we currently know?Front. Cell. Infect. Microbiol.20221167242910.3389/fcimb.2021.672429 35118003
    [Google Scholar]
  45. RavelJ. MorenoI. SimónC. Bacterial vaginosis and its association with infertility, endometritis, and pelvic inflammatory disease.Am. J. Obstet. Gynecol.2021224325125710.1016/j.ajog.2020.10.019 33091407
    [Google Scholar]
  46. MoneyD. The laboratory diagnosis of bacterial vaginosis.Can. J. Infect. Dis. Med. Microbiol.2005162777910.1155/2005/230319 18159532
    [Google Scholar]
  47. TalapkoJ. JuzbašićM. MatijevićT. Candida albicans-the virulence factors and clinical manifestations of infection.J. Fungi2021727910.3390/jof7020079 33499276
    [Google Scholar]
  48. KumwendaP. CottierF. HendryA.C. Estrogen promotes innate immune evasion of Candida albicans through inactivation of the alternative complement system.Cell Rep.202238111018310.1016/j.celrep.2021.110183 34986357
    [Google Scholar]
  49. BlaganjeM. BarbičM. Vaginal yeast infection.Curr. Bladder Dysfunct. Rep.202015432533110.1007/s11884‑020‑00606‑z
    [Google Scholar]
  50. DavisA. DasguptaA. Goddard-EckrichD. El-BasselN. Trichomonas vaginalis and human immunodeficiency virus coinfection among women under community supervision: A call for expanded T. Vaginalis screening.Sex. Transm. Dis.2016431061762210.1097/OLQ.0000000000000503 27631355
    [Google Scholar]
  51. TatarchukT.F. KaluginaL.V. PetrovaG.A. RadchenkoV.V. ShaverskaV.V. SorokinaA.M. Vaginal discharge syndrome. Problem with many unknowns.Reprod Endocrinol2020539410010.18370/2309‑4117.2020.53.94‑100
    [Google Scholar]
  52. Ortiz-de la TablaV. GutiérrezF. Cervicitis: Etiology, diagnosis and treatment.Enferm. Infecc. Microbiol. Clin.2019371066166710.1016/j.eimce.2018.12.011 30630634
    [Google Scholar]
  53. LuskM.J. KonecnyP. Cervicitis: A review.Curr Opin Intern Med20087214214810.1097/QCO.0b013e3282f3d988 18192786
    [Google Scholar]
  54. SefahN. NdebeleS. PrinceL. Uterine fibroids — Causes, impact, treatment, and lens to the African perspective.Front. Pharmacol.202313104578310.3389/fphar.2022.1045783 36703761
    [Google Scholar]
  55. StikaC.S. Atrophic vaginitis.Dermatol. Ther.201023551452210.1111/j.1529‑8019.2010.01354.x 20868405
    [Google Scholar]
  56. SimM. LoganS. GohL.H. Vaginal discharge: Evaluation and management in primary care.Singapore Med. J.202061629730110.11622/smedj.2020088 32754764
    [Google Scholar]
  57. GuptaM. MajumdarS. BanerjeeS. PalS. MondalT. A double-blind randomized clinical trial of novel Ayurvedic muco-adhesive extended release vaginal tablet (NA) for treatment of leucorrhea.Int J Clin Obstet Gynaecol20204232433310.33545/gynae.2020.v4.i2f.545
    [Google Scholar]
  58. RaoV.L. MahmoodT. Vaginal discharge.Obstetrics, Gynaecol. Reprod. Med.2020301111810.1016/j.ogrm.2019.10.004
    [Google Scholar]
  59. RichardsonA. RobinsonA.J. Vaginal discharge.Medicine202250525425810.1016/j.mpmed.2022.02.002
    [Google Scholar]
  60. FrobeniusW. BogdanC. Diagnostic value of vaginal discharge, wet mount and vaginal pH - An update on the basics of gynecologic infectiology.Geburtshilfe Frauenheilkd.201575435536610.1055/s‑0035‑1545909 26028693
    [Google Scholar]
  61. StrasburgerV.C. GreydanusD.E. Eds. Gynecology: Vaginal discharge: Sensitivity of a wet mount. Pract Care Exam Rev 2017281171810.1542/9781610020732‑09
    [Google Scholar]
  62. DaviesJ. Origins and evolution of antibiotic resistance.Microbiologia199612191610.1128/MMBR.00016‑10 9019139
    [Google Scholar]
  63. SihraN. GoodmanA. ZakriR. SahaiA. MaldeS. Nonantibiotic prevention and management of recurrent urinary tract infection.Nat. Rev. Urol.2018151275077610.1038/s41585‑018‑0106‑x 30361493
    [Google Scholar]
  64. BurtonJ.P. CadieuxP.A. ReidG. Improved understanding of the bacterial vaginal microbiota of women before and after probiotic instillation.Appl. Environ. Microbiol.20036919710110.1128/AEM.69.1.97‑101.2003 12513982
    [Google Scholar]
  65. AbdelnaemS.A. Effect of self-care guidelines on knowledge and quality of life among faculty of nursing students with vaginal infection.Obstet. Gynecol. Int. J.201910110.15406/ogij.2019.10.00408
    [Google Scholar]
  66. ChowK. WootenD. AnnepallyS. BurkeL. EdiR. MorrisS.R. Impact of (recurrent) bacterial vaginosis on quality of life and the need for accessible alternative treatments.BMC Womens Health202323111210.1186/s12905‑023‑02236‑z 36934289
    [Google Scholar]
  67. JonesA. Bacterial vaginosis: A review of treatment, recurrence, and disparities.J. Nurse Pract.201915642042310.1016/j.nurpra.2019.03.010
    [Google Scholar]
  68. BilardiJ WalkerS SmithTM McNairR SomersMJ BellhouseC P14.05 Sexual contact is the trigger! women’s views and experience of the causes and triggers of bacterial vaginosis.Sex Transm Infect201591A199.3200.310.1136/sextrans‑2015‑052270.517
    [Google Scholar]
  69. ChenX. LuY. ChenT. LiR. The female vaginal microbiome in health and bacterial vaginosis.Front. Cell. Infect. Microbiol.20211163197210.3389/fcimb.2021.631972 33898328
    [Google Scholar]
  70. AdolfssonA. HaganderA. MahjoubipourF. LarssonP.G. How vaginal infections impact women’s everyday life <br/>—women’s lived experiences of bacterial vaginosis and recurrent vulvovaginal candidiasis.Advances in Sexual Medicine20177111910.4236/asm.2017.71001
    [Google Scholar]
  71. AlmutairiS. AlobaidO. Al-ZahraniM.A. AlkhameesM. AljuhaymanA. GhazwaniY. Urinary incontinence among Saudi women: Prevalence, risk factors, and impact on quality of life.Eur. Rev. Med. Pharmacol. Sci.202125206311631810.26355/eurrev_202110_27001 34730211
    [Google Scholar]
  72. WhiteT.K. NavarroP. WeverF. KingL. DillardL.R. KrapfJ. Psychosocial impact of recurrent urogenital infections: A review.Womens Health2023191745505723121653710.1177/17455057231216537 38099456
    [Google Scholar]
  73. NaberK.G. SaucedoT.J. WagenlehnerF.M.E. Psychosocial burden of recurrent uncomplicated urinary tract infections.GMS Infect. Dis.202210Doc0110.3205/id000078 35463815
    [Google Scholar]
  74. BilardiJ.E. WalkerS. Temple-SmithM. The burden of bacterial vaginosis: Women’s experience of the physical, emotional, sexual and social impact of living with recurrent bacterial vaginosis.PLoS One201389e7437810.1371/journal.pone.0074378 24040236
    [Google Scholar]
  75. BilardiJ. WalkerS. McNairR. Women’s management of recurrent bacterial vaginosis and experiences of clinical care: A qualitative study.PLoS One2016113e015179410.1371/journal.pone.0151794 27010725
    [Google Scholar]
  76. RashadR.M. MohamedS.E.H. EmaraA.H. ElsabieyI.F. Quality of life among women diagnosed with vaginal infection.Zagazig Nurs J20221815270
    [Google Scholar]
  77. HaghdoostS. PazandehF. KhabazkhoobM. LakB.T. Association between sexual and genital hygiene habits with the urinary tract infection during pregnancy: A case-control study.Int. J. Women’s Health Reprod. Sci.20198215816410.15296/ijwhr.2020.25
    [Google Scholar]
  78. MeadM.G. GrünebergR.N. Urinary tract infection in a clinic for sexually transmitted diseases.Sex. Transm. Infect.197854427427710.1136/sti.54.4.274 581068
    [Google Scholar]
  79. CroghanS.M. KhanJ.S.A. JacobP.T. FloodH.D. GiriS.K. The recurrent urinary tract infection health and functional impact questionnaire (RUHFI-Q): Design and feasibility assessment of a new evaluation scale.Can. J. Urol.20212831072910732 34129471
    [Google Scholar]
  80. BrusselmansJ. De SutterA. DevleesschauwerB. VerstraelenH. CoolsP. Scoping review of the association between bacterial vaginosis and emotional, sexual and social health.BMC Womens Health202323116810.1186/s12905‑023‑02260‑z 37029382
    [Google Scholar]
  81. AlahverdiF. KheirkhahM. JananiL. Treatment outcomes of vaginal infections on sexual function.J. Med. Life202013332933510.25122/jml‑2020‑0051 33072204
    [Google Scholar]
  82. FaughtB.M. ReyesS. Characterization and treatment of recurrent bacterial vaginosis.J. Womens Health20192891218122610.1089/jwh.2018.7383 31403349
    [Google Scholar]
  83. ZaborE.C. KlebanoffM. YuK. Association between periodontal disease, bacterial vaginosis, and sexual risk behaviours.J. Clin. Periodontol.2010371088889310.1111/j.1600‑051X.2010.01593.x 20636412
    [Google Scholar]
  84. Effect of Self-Care Guidelines on Quality of Life. Effect of self-care guidelines on quality of life, knowledge and practices among faculty of nursing students with vaginal infection.Min Scient Nurs J201841839310.21608/msnj.2018.187770
    [Google Scholar]
  85. TanT.C. TanK.T. TayE.H. ChonkarS.P. Vaginal discharge and recurrent vulvovaginal candidiasis.Pract Obstet Gynaecol Handb O&G Clin Gen Pract2014201456156910.1142/9789814522953_0053
    [Google Scholar]
  86. BilardiJE WalkerS Temple-SmithM McNairR SomersMJ BellhouseC P3.005 the burden of bacterial vaginosis: Women’s experience of living with recurrent bacterial vaginsosis.Sex Transm Infect201389A149.110.1136/sextrans‑2013‑051184.0465
    [Google Scholar]
  87. MoshfeghyZ. TahariS. JanghorbanR. NajibF.S. ManiA. SayadiM. Association of sexual function and psychological symptoms (depression, anxiety and stress) in women with recurrent vulvovaginal candidiasis.J. Turk. Ger. Gynecol. Assoc.2020212909610.4274/jtgga.galenos.2019.2019.0077 31640303
    [Google Scholar]
  88. IrvingG. MillerD. RobinsonA. ReynoldsS. CopasA.J. Psychological factors associated with recurrent vaginal candidiasis: A preliminary study.Sex. Transm. Infect.199874533433810.1136/sti.74.5.334 10195028
    [Google Scholar]
  89. LittleP. TurnerS. RumsbyK. Developing clinical rules to predict urinary tract infection in primary care settings: Sensitivity and specificity of near patient tests (dipsticks) and clinical scores.Br. J. Gen. Pract.200656529606612 16882379
    [Google Scholar]
  90. AggarwalN. LeslieS.W. LotfollahzadehS. Recurrent urinary tract infections.In: StatPearls.Treasure Island, FLStatPearls Publishing2024
    [Google Scholar]
  91. BeahmN.P. NicolleL.E. BurseyA. SmythD.J. TsuyukiR.T. The assessment and management of urinary tract infections in adults: Guidelines for pharmacists.Can. Pharm. J.2017150529830510.1177/1715163517723036 28894499
    [Google Scholar]
  92. GodboleG.P. CerrutoN. ChavadaR. Principles of assessment and management of urinary tract infections in older adults.J. Pharm. Pract. Res.202050327628310.1002/jppr.1650
    [Google Scholar]
  93. da SilvaJ.L.A. da FonsecaC.D. StummE.M.F. RochaR.M. da SilvaM.R. BarbosaD.A. Factors associated with urinary tract infection in a Nursing Home.Rev. Bras. Enferm.202174S2e20200813
    [Google Scholar]
  94. Urinary tract infection (UTI) - Symptoms and causes - Mayo Clinic.Mayo Found Med Res2019
    [Google Scholar]
  95. Peiffer-SmadjaN. AllisonR. JonesL.F. Preventing and managing urinary tract infections: Enhancing the role of community pharmacists—a mixed methods study.Antibiotics20209958310.3390/antibiotics9090583 32906824
    [Google Scholar]
  96. BeahmN.P. SmythD.J. TsuyukiR.T. Outcomes of urinary tract infection management by pharmacists (R x OUTMAP): A study of pharmacist prescribing and care in patients with uncomplicated urinary tract infections in the community.Can. Pharm. J.2018151530531410.1177/1715163518781175 31080530
    [Google Scholar]
  97. NoorS. IsmailM. KhanF. Potential drug-drug interactions in patients with urinary tract infections: A contributing factor in patient and medication safety.Front. Pharmacol.201910103210.3389/fphar.2019.01032 31607905
    [Google Scholar]
  98. AnsariJ.A. Drug interaction and pharmacist.J. Young Pharm.20102332633110.4103/0975‑1483.66807 21042495
    [Google Scholar]
  99. SabraR SafwanJ DabbousM Assessment of knowledge, attitude and practice of Lebanese pharmacists in providing patient counseling on urinary tract infection and its treatment. Pharm Pract2022202011010.18549/PharmPract.2022.2.2653 35919798
    [Google Scholar]
  100. SpigelmyerA. HowardC. RybakovI. BurwellS. SlainD. Impact of clinical pharmacist discharge prescription review on the appropriateness of antibiotic therapy: A retrospective comparison.Int. J. Clin. Pharm.202345376977310.1007/s11096‑022‑01503‑7 36418632
    [Google Scholar]
  101. WuJ.H.C. KhalidF. LangfordB.J. Community pharmacist prescribing of antimicrobials: A systematic review from an antimicrobial stewardship perspective.Can. Pharm. J.2021154317919210.1177/1715163521999417 34104272
    [Google Scholar]
  102. BoothJ.L. MullenA.B. ThomsonD.A.M. Antibiotic treatment of urinary tract infection by community pharmacists: A cross-sectional study.Br. J. Gen. Pract.201363609e244e24910.3399/bjgp13X665206 23540480
    [Google Scholar]
  103. LlorC. BjerrumL. Antimicrobial resistance: risk associated with antibiotic overuse and initiatives to reduce the problem.Ther. Adv. Drug Saf.20145622924110.1177/2042098614554919 25436105
    [Google Scholar]
  104. BazzazF.B.S. ForkD.S. AhmadiR. KhamenehB. Deep insights into urinary tract infections and effective natural remedies.Afr. J. Urol.2021271610.1186/s12301‑020‑00111‑z
    [Google Scholar]
  105. JonesW. DrakeC. MackD. ReederB. TrautnerB. WaldH. Developing mobile clinical decision support for nursing home staff assessment of urinary tract infection using goal-directed design.Appl. Clin. Inform.20178263265010.4338/ACI‑2016‑12‑RA‑0209 28636060
    [Google Scholar]
  106. TradewellM. PariserJ.J. NimehT. ElliottS.P. Systematic review and practice policy statements on urinary tract infection prevention in adults with spina bifida.Transl. Androl. Urol.20187S2S205S21910.21037/tau.2018.04.21 29928619
    [Google Scholar]
  107. GrigoryanL. MulgirigamaA. PowellM. SchmiemannG. The emotional impact of urinary tract infections in women: A qualitative analysis.BMC Womens Health202222118210.1186/s12905‑022‑01757‑3 35585572
    [Google Scholar]
  108. VelaM.B. EronduA.I. SmithN.A. PeekM.E. WoodruffJ.N. ChinM.H. Eliminating explicit and implicit biases in health care: Evidence and research needs.Annu. Rev. Public Health202243147750110.1146/annurev‑publhealth‑052620‑103528 35020445
    [Google Scholar]
  109. GonzalezG. VaculikK. KhalilC. Using large-scale social media analytics to understand patient perspectives about urinary tract infections: Thematic analysis.J. Med. Internet Res.2022241e2678110.2196/26781 35076404
    [Google Scholar]
  110. DuszynskaW. RosenthalV.D. SzczesnyA. ZajaczkowskaK. FulekM. TomaszewskiJ. Device associated –health care associated infections monitoring, prevention and cost assessment at intensive care unit of University Hospital in Poland (2015–2017).BMC Infect. Dis.202020176110.1186/s12879‑020‑05482‑w 33066740
    [Google Scholar]
  111. LeckyD.M. GranierS. AllisonR. VerlanderN.Q. CollinS.M. McNultyC.A.M. Infectious disease and primary care research—what English general practitioners say they need.Antibiotics20209526510.3390/antibiotics9050265 32443700
    [Google Scholar]
  112. MoradpourS. ShahnaziH. HassanzadehA. Application of theory of planned behavior in pregnant women training regarding urinary tract infection prevention behaviors: A randomized controlled trial.Community Health Equity Res. Policy202343441342010.1177/0272684X211047064 37264673
    [Google Scholar]
  113. YoungM. SmithM.A. Standards and evaluation of healthcare quality, safety, and person-centered care.In: StatPearls.Treasure Island, FLStatPearls Publishing2022
    [Google Scholar]
  114. CyranO. JagodzińskaM. NowickiM. Knowledge and usage of prevention measures against urinary tract infections among young women.J Family Med Prim Care Rev201921432933410.5114/fmpcr.2019.90161
    [Google Scholar]
  115. JohnsonC.Y. RocheleauC.M. HowleyM.M. ChiuS.K. ArnoldK.E. AilesE.C. Characteristics of women with urinary tract infection in pregnancy.J. Womens Health202130111556156410.1089/jwh.2020.8946 34491115
    [Google Scholar]
  116. KhauliR.B. HeidarA.N.F. DegheiliJ.A. YacoubianA.A. Management of urinary tract infection in women: A practical approach for everyday practice.Urol. Ann201911433934610.4103/UA.UA_104_19 31649450
    [Google Scholar]
  117. RatnerV. The interstitial cystitis association of America: Lessons learned over the past 30 years.Transl. Androl. Urol.20154549149810.3978/j.issn.2223‑4683.2015.09.02 26816848
    [Google Scholar]
  118. LeanK. NawazR.F. JawadS. VincentC. Reducing urinary tract infections in care homes by improving hydration.BMJ Open Qual.201983e00056310.1136/bmjoq‑2018‑000563 31363503
    [Google Scholar]
/content/journals/iddt/10.2174/0118715265286164240508064714
Loading
/content/journals/iddt/10.2174/0118715265286164240508064714
Loading

Data & Media loading...

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test